Cargando…

Microbiota Biomarkers for Lung Cancer

Non-small cell lung cancer (NSCLC) is the number one cancer killer and its early detection can reduce mortality. Accumulating evidences suggest an etiopathogenic role of microorganisms in lung tumorigenesis. Certain bacteria are found to be associated with NSCLC. Herein we evaluated the potential us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leng, Qixin, Holden, Van K., Deepak, Janaki, Todd, Nevins W., Jiang, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997424/ https://www.ncbi.nlm.nih.gov/pubmed/33673596 http://dx.doi.org/10.3390/diagnostics11030407

Ejemplares similares

Autoantibodies against tumor-associated antigens in sputum as biomarkers for lung cancer
por: Li, Ning, et al.
Publicado: (2020)

A Non-Coding RNA Landscape of Bronchial Epitheliums of Lung Cancer Patients
por: Lin, Yanli, et al.
Publicado: (2020)

Streptococcus pneumoniae promotes lung cancer development and progression
por: Li, Ning, et al.
Publicado: (2023)

Profiling Plasma Cytokines by A CRISPR-ELISA Assay for Early Detection of Lung Cancer
por: Li, Ning, et al.
Publicado: (2022)

Circulating Bacterial DNA as Plasma Biomarkers for Lung Cancer Early Detection
por: Zhou, Huifen, et al.
Publicado: (2023)

MicroRNA‐based biomarkers for diagnosis of non‐small cell lung cancer (NSCLC)
por: Liao, Jipei, et al.
Publicado: (2020)

Integrating Circulating Immunological and Sputum Biomarkers for the Early Detection of Lung Cancer
por: Su, Jian, et al.
Publicado: (2018)

A Direct Plasma miRNA Assay for Early Detection and Histological Classification of Lung Cancer
por: Leng, Qixin, et al.
Publicado: (2018)

An integromic signature for lung cancer early detection
por: Leng, Qixin, et al.
Publicado: (2018)

Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers
por: Shen, Jun, et al.
Publicado: (2011)

A Plasma Long Noncoding RNA Signature for Early Detection of Lung Cancer
por: Lin, Yanli, et al.
Publicado: (2018)

Plasma microRNAs as potential biomarkers for non-small-cell lung cancer
por: Shen, Jun, et al.
Publicado: (2011)

Combined Pulmonary Fibrosis and Emphysema: Pulmonary Function Testing and a Pathophysiology Perspective
por: Amariei, Diana E., et al.
Publicado: (2019)

Centrilobular emphysema combined with pulmonary fibrosis results in improved survival
por: Todd, Nevins W, et al.
Publicado: (2011)

Incidental Pulmonary Nodules and Lung Cancer Screening
por: Patel, Pooja, et al.
Publicado: (2023)

A plasma miRNA signature for lung cancer early detection
por: Leng, Qixin, et al.
Publicado: (2017)

Lung Cancer Screening in Patients with COPD—A Case Report
por: Amirahmadi, Roxana, et al.
Publicado: (2019)

IMPACT OF COVID-19 PANDEMIC ON DIAGNOSIS AND TREATMENT OF LUNG CANCER IN THE VETERAN COHORT
por: ABBAS, HATOON, et al.
Publicado: (2021)

A CRISPR Test for Rapidly and Sensitively Detecting Circulating EGFR Mutations
por: Tsou, Jen-Hui, et al.
Publicado: (2020)

A CRISPR Test for Detection of Circulating Nuclei Acids
por: Tsou, Jen-Hui, et al.
Publicado: (2019)

Rapidly progressive interstitial lung disease due to anti-melanoma differentiation associated protein-5 requiring a bilateral lung transplant, and complicated by kennel cough
por: Deitchman, Andrew R., et al.
Publicado: (2019)

Characterizing microbiota and metabolomics analysis to identify candidate biomarkers in lung cancer
por: Liu, Bo, et al.
Publicado: (2022)

Complex obstructive lung disease – A diagnostic and management conundrum
por: Glick, Danielle R., et al.
Publicado: (2020)

Sensitive Detection of KRAS Mutations by Clustered Regularly Interspaced Short Palindromic Repeats
por: Zhou, Huifen, et al.
Publicado: (2021)

ALDH1A1 Is a Marker for Malignant Prostate Stem Cells and Predictor of Prostate Cancer Patients’ Outcome
por: Li, Ting, et al.
Publicado: (2009)

Cigarette Smoke Particle-Induced Lung Injury and Iron Homeostasis
por: Ghio, Andrew J, et al.
Publicado: (2022)

Interstitial Lung Disease and Pulmonary Fibrosis: A Practical Approach for General Medicine Physicians with Focus on the Medical History
por: Kalchiem-Dekel, Or, et al.
Publicado: (2018)

Survival in pulmonary fibrosis combined with emphysema: likely defined by characteristics of specific patient subpopulations
por: Todd, Nevins W, et al.
Publicado: (2011)

The Effect of a Dedicated Lung Mass Clinic on Lung Nodule Follow Up
por: Kumar, Avnee J, et al.
Publicado: (2022)

Microbiota: An Emerging Biomarker in Colorectal Cancer
por: Tsiaoussis, John, et al.
Publicado: (2021)

A prediction model for distinguishing lung squamous cell carcinoma from adenocarcinoma
por: Li, Hui, et al.
Publicado: (2017)

Caplan’s Syndrome with a twist
por: Deepak, Janaki, et al.
Publicado: (2020)

Identification of gastric microbiota biomarker for gastric cancer
por: Dang, Yi-Ni, et al.
Publicado: (2020)

Oral Microbiota as Novel Biomarkers for Colorectal Cancer Screening
por: Rezasoltani, Sama, et al.
Publicado: (2022)

Molecular and cellular mechanisms of pulmonary fibrosis
por: Todd, Nevins W, et al.
Publicado: (2012)

Mucosal microbiota of intestinal polyps reveals putative biomarkers of colorectal cancer
por: Mangifesta, Marta, et al.
Publicado: (2018)

Role of lung and gut microbiota on lung cancer pathogenesis
por: Zhao, Yue, et al.
Publicado: (2021)

The Lung Microbiota and Lung Cancer: A Growing Relationship
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

Modified branched peptides with a histidine-rich tail enhance in vitro gene transfection
por: Leng, Qixin, et al.
Publicado: (2005)

Circulating Neutrophil MicroRNAs as Biomarkers for the Detection of Lung Cancer
por: Ma, Jie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_b5a66bd7sikqr4p570ot1i72ju